Muhammed A Alsherbiny

17PUBLICATIONS
23CO-AUTHORS
Neurology and neuromuscular diseasesCancer therapy (excl. chemotherapy and radiation therapy)Food properties (incl. characteristics and health benefits)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Mar 28, 2026
Plasma proteomics implicates NOX-driven redox imbalance in degenerative cervical myelopathy: findings from the Australian MYelopathy Natural History Registry [AO Spine RECODE-DCM research priority number 5].

Nashwa Najib, Valerie C Wasinger, Ryan O'Hare Doig

|Jan 10, 2026
Postbiotics Combination Synergises the Antiproliferative Effects of Doxorubicin in Gastric Cancer Cells: A Cellular and Molecular Deep Dive.

Radwa A Eladwy, Mohamed Fares, Muhammad A Alsherbiny

|Oct 16, 2025
Guardians in the Gut: Mechanistic Insights into a Hidden Ally Against Triple-Negative Breast Cancer.

Kayla Jaye, Muhammad A Alsherbiny, Dennis Chang

|Aug 14, 2025
Investigating the Cellular Responses to Combined Nisin and Urolithin B Treatment (7:3) in HKB-11 Lymphoma Cells.

Ahmad K Al-Khazaleh, Muhammad A Alsherbiny, Dennis Chang

|Aug 14, 2025
Fuelling the Fight from the Gut: Short-Chain Fatty Acids and Dexamethasone Synergise to Suppress Gastric Cancer Cells.

Radwa A Eladwy, Mohamed Fares, Dennis Chang

|Jul 29, 2025
Gut Microbial Postbiotics as Potential Therapeutics for Lymphoma: Proteomics Insights of the Synergistic Effects of Nisin and Urolithin B Against Human Lymphoma Cells.

Ahmad K Al-Khazaleh, Muhammad A Alsherbiny, Gerald Münch

Pageof 3

Frequent Collaborators

10 joint publications

Deep Jyoti Bhuyan

4 joint publications

Chunguang Li

2 joint publications

Mitchell N Low

2 joint publications

Shymaa A El Badawy